From: Correlation of MLH1 and MGMTexpression and promoter methylation with genomic instability in patients with thyroid carcinoma
MSI status
PTC
FTC
Benign
N (%)
p*
MSI
59/70 (84%)
0.002
11/12 (92%)
0.012
6/14 (43%)
MSI-H
38/59 (64%)
9/11 (82%)
-
MSI-L
21/59 (46%)
2/11 (18%)
6/6 (100%)